MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.
about
Microparticles Mediate the Intercellular Regulation of microRNA-503 and Proline-Rich Tyrosine Kinase 2 to Alter the Migration and Invasion Capacity of Breast Cancer Cells.miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1miR-503 represses human cell proliferation and directly targets the oncogene DDHD2 by non-canonical target pairing.By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.MicroRNAs in pulmonary arterial hypertension.Small nucleolar RNA 78 promotes the tumorigenesis in non-small cell lung cancerMicroRNAs in apoptosis, autophagy and necroptosisEndothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer.MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.SOSTDC1 is down-regulated in non-small cell lung cancer and contributes to cancer cell proliferation.MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptorMicroRNA-181b is downregulated in non-small cell lung cancer and inhibits cell motility by directly targeting HMGB1.MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy.Membrane microparticles: shedding new light into cancer cell communication.Increased expression of microRNA-503 and reduced expression of kangai-1 in B-cell non-Hodgkin's lymphoma.miR-297 acts as an oncogene by targeting GPC5 in lung adenocarcinoma.A negative feedback loop between miR-200b and the nuclear factor-κB pathway via IKBKB/IKK-β in breast cancer cells.MicroRNA-575 targets BLID to promote growth and invasion of non-small cell lung cancer cells.Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer.Targeting IGF1R pathway in cancer with microRNAs: How close are we ?miR-503 inhibits cell proliferation and invasion in glioma by targeting L1CAM.MiR-503 modulates epithelial-mesenchymal transition in silica-induced pulmonary fibrosis by targeting PI3K p85 and is sponged by lncRNA MALAT1MicroRNA‑503 serves an oncogenic role in laryngeal squamous cell carcinoma via targeting programmed cell death protein 4.miR-503-3p induces apoptosis of lung cancer cells by regulating p21 and CDK4 expression.CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles.microRNA-503 suppresses the migration, proliferation and colony formation of prostate cancer cells by targeting tumor protein D52 like 2.Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85.Interaction between CD133 and PI3K-p85 promotes chemoresistance in gastric cancer cells.MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas.Deletion of IκB-Kinase β in Smooth Muscle Cells Induces Vascular Calcification Through β-Catenin-Runt-Related Transcription Factor 2 Signaling.miR-503 suppresses the proliferation and metastasis of esophageal squamous cell carcinoma by triggering autophagy via PKA/mTOR signaling.The Destiny of Glucose from a MicroRNA Perspective.MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression.[Effect of PI3K/AKT pathway on cisplatin resistance in non-small cell lung cancer].mTOR signaling-related MicroRNAs and Cancer involvement.miR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1Inhibition of Prostate Cancer DU-145 Cells Proliferation by Oligopeptide (YVPGP) via PI3K/AKT/mTOR Signaling Pathway
P2860
Q34048932-9817DECB-76EF-45C1-9D58-8F4658744C9BQ34072324-D1EFACC0-0F86-49B5-B09A-BF7F160F0D7EQ35079173-FFF3ED21-0C4F-4351-8046-9019D521E1E0Q35176335-3E45E760-4582-427F-B1D9-2C268E3B07D9Q35207669-18CEB3E4-D587-42F4-A05F-0620130EA06AQ35755323-3BC6C225-6490-4F98-9D91-9CD63CE9195EQ35832148-F8469400-CB17-4272-B6C1-C43E0BBC4D7EQ35832970-6EC94414-105F-4391-B051-74706F4F8DF8Q35881020-24E24D45-1519-447C-A152-942CC82FB707Q36212307-DEDC6CDF-3112-434D-9F90-51F3BF6258A0Q36800327-A783EA55-E2B5-4231-8A5B-22BE985C01E0Q37021246-67FA2395-260A-4725-B0FD-36B15B199254Q37407338-3DD5E1EE-7C3A-4FE5-8163-C8197501FAC1Q38258284-0034FB5B-204D-4E6B-B8DD-755EA8246087Q38569109-1F644568-0D35-4086-9EF1-698FB9D0DBD4Q38719072-9DCE10F6-0F70-46B2-A27E-53C72197A437Q38750546-741F5E1B-A1AC-4758-B861-1E548DF2FB5FQ38830564-A4724D21-C868-485D-9659-754BF4A74A1FQ38904926-17888629-C297-4976-9E32-9EB0543E13C1Q39254692-A2EE451A-7E18-45A1-ACB3-314827D72D72Q39371841-F82F70DB-1C83-4B82-87BA-0D5FA3971161Q40104799-EDED8060-BDC3-40BA-B74D-8994954EF189Q41193504-7E7A7854-97EF-4B28-9F9F-2D1FB9A7BDA2Q42678973-5E5E127B-1DA2-4512-8EA9-47A3E20C161EQ42777329-52AFC16D-3957-4370-960C-7D9EF8961167Q47347862-C673E760-715F-4837-9D9E-B0DAE87F21ADQ47708532-1E07CA47-5B81-4D51-8B69-3BFAC7F14BB9Q48256677-AFF64F72-6D54-44DA-991F-2432C41A104AQ49242542-F6290223-6CC9-4B6D-A19E-84A3CA66ED29Q49409530-5A0B28C2-290F-40F1-8730-2061B653C2E5Q50187886-3C74F3A5-AE42-44B1-91C3-0626927AF5DAQ52641340-5EB86C4A-7A7A-4DC9-A2BA-04C975080105Q52657176-C6EF5683-BF6D-4ED3-AC4E-E7C2D387619CQ52938405-40CB859D-E54F-458F-AD7E-571BEFC87AB1Q54329431-64444CFF-60A8-4618-B6B8-02C02A9716CBQ55069878-FFD2F560-1DC9-4B09-9CAB-8D7CDECE0352Q57128464-A688D13D-A59B-42E4-A89C-D501C5E2A37BQ57158527-2FADFDEA-A162-4848-8C3C-5A7FECA524F4
P2860
MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
MiR-503 targets PI3K p85 and I ...... of non-small cell lung cancer.
@en
MiR-503 targets PI3K p85 and I ...... of non-small cell lung cancer.
@nl
type
label
MiR-503 targets PI3K p85 and I ...... of non-small cell lung cancer.
@en
MiR-503 targets PI3K p85 and I ...... of non-small cell lung cancer.
@nl
prefLabel
MiR-503 targets PI3K p85 and I ...... of non-small cell lung cancer.
@en
MiR-503 targets PI3K p85 and I ...... of non-small cell lung cancer.
@nl
P2093
P2860
P356
P1476
MiR-503 targets PI3K p85 and I ...... of non-small cell lung cancer.
@en
P2093
Hongyu Guan
Jueheng Wu
Mengfeng Li
Ying Zhang
P2860
P304
P356
10.1002/IJC.28799
P577
2014-03-27T00:00:00Z